Thursday 29 October 2015

Cancer-fighting viruses win approval

Cancer-fighting viruses win approval

An engineered herpesvirus that provokes an immune response against cancer has become the first treatment of its kind to be approved for use in the United States, paving the way for a long-awaited class of therapies. On 27 October, the US Food and Drug Administration (FDA) approved a genetically engineered virus called talimogene laherparepvec (T-VEC) to treat advanced melanoma. Four days earlier, advisers to the European Medicines Agency had endorsed the drug.
Read more: http://ift.tt/1iobSIX

No comments:

Post a Comment